Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease.Published in:Molecular Therapy, 2007, v. 15, n. 6, p. 1100, doi. 10.1038/sj.mt.6300163By:Howarth, J. L.;Kelly, S.;Keasey, M. P.;Glover, C. P. J.;Lee, Y.-B.;Mitrophanous, K.;Chapple, J. P.;Gallo, J. M.;Cheetham, M. E.;Uney, J. B.Publication type:Article